NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

生物製劑市場規模調查:按產品,用途劃分的COVID-19的累積影響(∼2025年)

Biologics Market Research Report by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 989812
出版日期 內容資訊 英文 186 Pages
商品交期: 最快1-2個工作天內
價格
生物製劑市場規模調查:按產品,用途劃分的COVID-19的累積影響(∼2025年) Biologics Market Research Report by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 186 Pages
簡介

全球生物製劑市場預計將從2020年的246,272.01百萬美元增長到2025年底的304,866.47百萬美元。

市場細分和覆蓋範圍:

該研究對全球生物製品市場進行分類,預測收入並分析以下每個子市場的趨勢:

通過產品,人們在基於細胞的生物製劑,基於基因的生物製劑,單克隆抗體,重組激素/蛋白質和疫苗等領域探索了生物製劑市場。

通過應用,研究了生物製藥市場中的自身免疫性疾病,癌症,傳染病和罕見病。

按地區,對美洲,亞太地區,歐洲和中東/非洲的生物製品市場進行了調查。

COVID-19的累積影響:

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該調查提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

報告提供了有關以下準則的見解:

  • 1. 市場滲透率:主要參與者提供的全面市場信息
  • 2. 市場開發:有利可圖的新興市場的詳細信息和市場分析
  • 3. 市場多元化:有關新產品發佈,欠發達地區,最新發展和投資的更多信息
  • 4. 競爭評估和情報:全面評估領先公司的市場份額,戰略,產品和製造能力
  • 5. 產品開發和創新:對未來技術,研發活動和新產品開發的見解

報告回答以下問題:

1.全球生物製劑市場的規模和預測是什麼?

2.在預測期內,COVID-19構成全球生物製品市場的抑制因素和影響是什麼?

3.在全球生物製劑市場的預測期內,您將投資哪些產品/細分/用途/領域?

4.全球生物製劑市場中機會的競爭戰略窗口是什麼?

5.全球生物製品市場趨勢什麼是技術趨勢和監管框架?

6.哪些模式和戰略舉措被認為適合進入全球生物製劑市場?

本報告調查了生物製藥市場,分析了市場概況,市場增長和障礙,市場規模趨勢以及按產品,應用和地區,主要競爭對手的概況和概況進行的預測,並提供了諸如市場機會之類的全面信息。

目錄

第1章前言

  • 調查目的
  • 市場細分和覆蓋範圍
  • 調查對像年度
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 簡介
  • 市場前景
  • 產品前景
  • 按應用程序劃分的Outlook
  • 區域展望
  • 競爭對手的展望

第4章市場概述

  • 簡介
  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • 搬運工五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章全球生物製品市場(按產品)

  • 簡介
  • 細胞生物製劑
  • 基因生物製劑
  • 單克隆抗體
  • 重組激素/蛋白質
  • 疫苗

第7章,按用途分列的全球生物製品市場

  • 簡介
  • 自身免疫性疾病
  • 癌症
  • 傳染病
  • 罕見疾病

第8章美洲生物製品市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太生物製品市場

  • 簡介
  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章歐洲,中東和非洲的生物製品市場

  • 簡介
  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第11章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情景
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,獎項,擴展

第12章企業可用性簡介

  • AbbVie Inc.
  • Amgen, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi SA

第13章附錄

  • 討論指南

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-4302AC722017

The Global Biologics Market size was estimated at USD 247.82 Billion in 2020 and expected to reach USD 259.87 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 5.19% to reach USD 335.91 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Biologics Market was studied across Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines. The Monoclonal Antibodies is further studied across Diagnostic and Therapeutic.

Based on Application, the Biologics Market was studied across Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases.

Based on Geography, the Biologics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Market, including AbbVie Inc., Allergan, Amgen Inc, Apogenix, AstraZeneca, Bayer AG, Biocon, BioMarin Pharmaceutical, Celltrion, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gangagen, GlaxoSmithKline PLC, GSK group of companies, Johnson & Johnson, Medexus Pharma, Merck & Co., Novo Nordisk AS, Pfizer Inc., Precision Biologics, Inc., Samsung BioLogics, Sanofi SA, Theratome Bio, Tubulis Technologies, and Vaximm.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Biologics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Biologics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Biologics Market?
  • 6. What is the market share of the leading vendors in the Global Biologics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Biologics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Application Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Attractive investment in the market from players across value chain
      • 5.1.1.2. Rising prevalence of chronic diseases
      • 5.1.1.3. Patent loss of leading biologic drugs
      • 5.1.1.4. Availability of advanced diagnostics and rising government initiatives in healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory process coupled with high capital investment
    • 5.1.3. Opportunities
      • 5.1.3.1. Higher acceptability for innovative therapies
      • 5.1.3.2. Technological advancements in research and development across the globe
    • 5.1.4. Challenges
      • 5.1.4.1. Tightly controlled atmospheric conditions and maintained production process
      • 5.1.4.2. Cost associated with access of biologics
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Biologics Market, by Product

  • 6.1. Introduction
  • 6.2. Cellular Based Biologics
  • 6.3. Gene Based Biologics
  • 6.4. Monoclonal Antibodies
    • 6.4.1. Diagnostic
      • 6.4.1.1. Biochemical Analysis
      • 6.4.1.2. Diagnostic Imaging
    • 6.4.2. Therapeutic
      • 6.4.2.1. Direct MAB Agents
      • 6.4.2.2. Targeting MAB Agents
  • 6.5. Recombinant Hormones/Proteins
  • 6.6. Vaccines

7. Biologics Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cancer
  • 7.4. Infectious Diseases
  • 7.5. Rare Diseases

8. Americas Biologics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Biologics Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Biologics Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. AbbVie Inc.
  • 12.2. Allergan
  • 12.3. Amgen Inc
  • 12.4. Apogenix
  • 12.5. AstraZeneca
  • 12.6. Bayer AG
  • 12.7. Biocon
  • 12.8. BioMarin Pharmaceutical
  • 12.9. Celltrion
  • 12.10. Eli Lilly and Company
  • 12.11. F. Hoffmann-La Roche AG
  • 12.12. Gangagen
  • 12.13. GlaxoSmithKline PLC
  • 12.14. GSK group of companies
  • 12.15. Johnson & Johnson
  • 12.16. Medexus Pharma
  • 12.17. Merck & Co.
  • 12.18. Novo Nordisk AS
  • 12.19. Pfizer Inc.
  • 12.20. Precision Biologics, Inc.
  • 12.21. Samsung BioLogics
  • 12.22. Sanofi SA
  • 12.23. Theratome Bio
  • 12.24. Tubulis Technologies
  • 12.25. Vaximm

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL BIOLOGICS MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL BIOLOGICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, 2018-2026 (USD BILLION)
  • FIGURE 27. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 31. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 33. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 35. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, 2018-2026 (USD BILLION)
  • FIGURE 38. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 44. AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 46. ARGENTINA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. BRAZIL BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. CANADA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. MEXICO BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. UNITED STATES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. CALIFORNIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. FLORIDA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. ILLINOIS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. NEW YORK BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. OHIO BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. PENNSYLVANIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. TEXAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 59. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 61. CHINA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. INDIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. INDONESIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. JAPAN BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. MALAYSIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. PHILIPPINES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. SOUTH KOREA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. THAILAND BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 70. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 71. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 72. FRANCE BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. GERMANY BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. ITALY BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. NETHERLANDS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 76. QATAR BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. RUSSIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 78. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 80. SPAIN BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 81. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 82. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 83. GLOBAL BIOLOGICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 84. GLOBAL BIOLOGICS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 85. GLOBAL BIOLOGICS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 86. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY CELLULAR BASED BIOLOGICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY GENE BASED BIOLOGICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL BIOLOGICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL BIOLOGICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL BIOLOGICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL BIOLOGICS MARKET SIZE, BY THERAPEUTIC, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL BIOLOGICS MARKET SIZE, BY DIRECT MAB AGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL BIOLOGICS MARKET SIZE, BY TARGETING MAB AGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL BIOLOGICS MARKET SIZE, BY RECOMBINANT HORMONES/PROTEINS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL BIOLOGICS MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL BIOLOGICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL BIOLOGICS MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL BIOLOGICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL BIOLOGICS MARKET SIZE, BY RARE DISEASES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. AMERICAS BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. AMERICAS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. AMERICAS BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. ARGENTINA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. ARGENTINA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. BRAZIL BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. BRAZIL BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. CANADA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. CANADA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. MEXICO BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. MEXICO BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. UNITED STATES BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. UNITED STATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. UNITED STATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. CALIFORNIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. CALIFORNIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. FLORIDA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. FLORIDA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. ILLINOIS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. ILLINOIS BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. NEW YORK BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. NEW YORK BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. OHIO BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. OHIO BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. PENNSYLVANIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. PENNSYLVANIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. TEXAS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. TEXAS BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. ASIA-PACIFIC BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. CHINA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. CHINA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. INDIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. INDIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. INDONESIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. INDONESIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. JAPAN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. JAPAN BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. MALAYSIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. MALAYSIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. PHILIPPINES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. PHILIPPINES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. SOUTH KOREA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. SOUTH KOREA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. THAILAND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. THAILAND BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. FRANCE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. FRANCE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. GERMANY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. GERMANY BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. ITALY BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. ITALY BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. NETHERLANDS BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. NETHERLANDS BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. QATAR BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. QATAR BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. RUSSIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. RUSSIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. SAUDI ARABIA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. SOUTH AFRICA BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. SPAIN BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. SPAIN BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. UNITED ARAB EMIRATES BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. UNITED KINGDOM BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. GLOBAL BIOLOGICS MARKET: SCORES
  • TABLE 93. GLOBAL BIOLOGICS MARKET: BUSINESS STRATEGY
  • TABLE 94. GLOBAL BIOLOGICS MARKET: PRODUCT SATISFACTION
  • TABLE 95. GLOBAL BIOLOGICS MARKET: RANKING
  • TABLE 96. GLOBAL BIOLOGICS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 97. GLOBAL BIOLOGICS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 98. GLOBAL BIOLOGICS MARKET: MERGER & ACQUISITION
  • TABLE 99. GLOBAL BIOLOGICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 100. GLOBAL BIOLOGICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 101. GLOBAL BIOLOGICS MARKET: INVESTMENT & FUNDING
  • TABLE 102. GLOBAL BIOLOGICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 103. GLOBAL BIOLOGICS MARKET: LICENSE & PRICING
  • TABLE 104. GLOBAL BIOLOGICS MARKET: CONTACT DETAILS